Used in the pharmaceutical industry as a key intermediate in the synthesis of various bioactive compounds. It plays a role in the development of drugs targeting central nervous system disorders, including antidepressants and anxiolytics. The cyclopropyl and trifluoromethyl groups enhance the molecule's stability and binding affinity to biological targets. Additionally, it is explored in the creation of novel therapeutic agents for treating chronic pain and inflammation. Its unique structure makes it valuable in medicinal chemistry for optimizing drug efficacy and selectivity.